HIGHLIGHTS
- who: Pierre Decazes and colleagues from the Department of Medical Imaging and Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France QuantIF-LITIS (EA [Equipe d` Accueil], ), Faculty of Medicine, University of Rouen, Rouen, France have published the research work: Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs, in the Journal: Diagnostics 2023, 13, x FOR PEER REVIEW A of /2023/
- what: The aim of this study is to evaluate the prognostic value of 3D and 2D anthropometric parameters in patients given treatments. The authors investigated the contribution of body composition in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.